Thrombosis in a patient with combined homozygosity for the factor V Leiden mutation and a mutation in the 3'-untranslated region of the prothrombin gene

Blood Coagulation and Fibrinolysis

Volumn 10, Issue 2, 1999, Pages 107-110

  Wulf, G M ^d   Van Deerlin, V M D ^b   Leonard, D G B ^b   Bauer, Kenneth A ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c VA BOSTON HEALTHCARE SYSTEM   (United States)

^d NONE

Author keywords

Thrombosis, mutation, factor V Leiden, prothrombin gene mutation

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 5; PROTHROMBIN; WARFARIN;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; GENE MUTATION; GENOTYPE; HOMOZYGOSITY; HUMAN; MALE; PEDIGREE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; THROMBOSIS; VEIN THROMBOSIS;

EID: 0033004944     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199903000-00008     Document Type: Article

References (12)

1. 1. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67.
2. 2. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-3703.
3. 3. Price DT, Ridker PM. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective. Ann Intern Med 1997; 127: 895-903.
4. 4. Bertina RM. Factor V Leiden and other coagulation factor mutations affecting thrombotic risk. Clin Chem 1997; 43: 1678-1683.
5. 5. Bauer KA. Hypercoagulable states. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Cohen HJ, Silberstein LE (editors): Hematology: basic principles and clinical practice. 2nd edition. New York: Churchill Livingstone; 1995. pp. 1781-1795.
6. 6. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Eng J Med 1995; 332: 912-917.
7. 7. Hillarp A, Zöller B, Svensson P, Dahlbäck B. The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep vein thrombosis. Thromb Haemost 1997; 78: 990-992.
8. 8. Arruda VR, Annichino-Bizzacchi JM, Gonçalves MS, Costa FF. Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease. Thromb Haemost 1997; 78: 1430-1433.
9. 9. Kapur RK, Mills LA, Spitzer SG, Hultin MB. A prothrombin gene mutation is significantly associated with venous thrombosis. Arteriosder Thromb Vasc Biol 1997; 17: 2875-2879.
10. 10. Makris M, Preston FE, Beauchamp NJ, Cooper PC, Daly ME, Hampton KK, et al. Co-inheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia. Thromb Haemost 1997; 78: 1426-1429.
11. 11. Miletich JP, Prescott SM, White R, Majerus PW, Bovill EG. Inherited predisposition to thrombosis. Cell 1993; 72: 477-480.
12. 12. Schafer AI. Hypercoagulable states: molecular genetics to clinical practice. Lancet 1994; 344: 1739-1742.